Advia 2400 Chemistry System, Automated Clinical Chemistry Analyzer - human serum, plasma and urine tests
Bayer Healthcare, LLC (Diagnostics Division) began a recall of Advia 2400 Chemistry System, Automated Clinical Chemistry Analyzer - human serum, plasma and urine tests on . The reason FDA records is "Low QC recovery observed on carbamazepine (CARB) results immediately following a Gentamicin (GENT) assay or a Digoxin (DIG) assay. When GENT or DIG precedes CARB, the CARB test result is artificially low (as much as...". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-1450-06
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Siemens Healthcare Diagnostics Inc.
- Product
- Advia 2400 Chemistry System, Automated Clinical Chemistry Analyzer - human serum, plasma and urine tests.
- Product code
- JGS Electrode, Ion Specific, Sodium
- Reason for recall
- Low QC recovery observed on carbamazepine (CARB) results immediately following a Gentamicin (GENT) assay or a Digoxin (DIG) assay. When GENT or DIG precedes CARB, the CARB test result is artificially low (as much as -25%). PHNY was determined to also exhibit a similar carryover effect on CARB. All others were found not to produce the same reagent probe-based carryover effect.
- FDA root cause
- Other
- Action
- Bayer HealthCare LLC issued a Support Bulletin to all affected Bayer HealthCare LLC Branches on/about 2/17/06 in order to inform them of the issue and to provide them with instructions for this ''field correction''. Customer Bulletins were also issued to the Branches both in the United States and elsewhere for communication with the affected customers.
- Quantity in commerce
- 1138 for all products
- Distribution
- Worldwide including USA and Puerto Rico.
- Product codes and lots
- Part No. 073-A010; all Advia Chemistry System units are serial numbers are involved in this ''field correction'' as well as existing assay lots for CARB, PHNY, GENT and DIG.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
